Lysine 419 targets human glucocorticoid receptor for proteasomal degradation

Steroids

Volumn 75, Issue 12, 2010, Pages 1016-1023

  Wallace, Andrew D ^a   Cao, Yan ^a   Chandramouleeswaran, Sindhu ^a   Cidlowski, John A ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Dexamethasone; Glucocorticoid receptor; PEST; Proteasome inhibitor

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DEXAMETHASONE; EPOXOMICIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GREEN FLUORESCENT PROTEIN; LYSINE; PROTEASOME;

ARTICLE; CELL STRAIN COS1; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HELA CELL; HORMONE RESPONSE; HUMAN; HUMAN CELL; MUTAGENESIS; MUTANT; PROTEIN DEGRADATION; PROTEIN MOTIF; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INTRACELLULAR SPACE; LYSINE; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROMOTER REGIONS, GENETIC; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT; RATS; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 77955921192     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.06.015     Document Type: Article

References (48)

1. B.D. Jenkins, C.B. Pullen, and B.D. Darimont Novel glucocorticoid receptor coactivator effector mechanisms Trends Endocrinol Metab 12 3 2001 122 126
2. C.L. Smith, and B.W. O'Malley Coregulator function: a key to understanding tissue specificity of selective receptor modulators Endocr Rev 25 1 2004 45 71
3. I.M. Adcock, K. Ito, and P.J. Barnes Glucocorticoids: effects on gene transcription Proc Am Thorac Soc 1 3 2004 247 254
4. L.I. McKay, and J.A. Cidlowski CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism Mol Endocrinol 14 8 2000 1222 1234
5. J.A. Cidlowski, and N.B. Cidlowski Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells Endocrinology 109 6 1981 1975 1982
6. J.N. Vanderbilt, R. Miesfeld, B.A. Maler, and K.R. Yamamoto Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity Mol Endocrinol 1 1 1987 68 74
7. C.M. Silva, F.E. Powell-Oliver, C.M. Jewell, M. Sar, V.E. Allgood, and J.A. Cidlowski Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid Steroids 59 7 1994 436 442
8. Y. Dong, L. Poellinger, J.A. Gustafsson, and S. Okret Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms Mol Endocrinol 2 12 1988 1256 1264
9. K.L. Burnstein, C.M. Jewell, M. Sar, and J.A. Cidlowski Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms Mol Endocrinol 8 12 1994 1764 1773
10. W. Hoeck, S. Rusconi, and B. Groner Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment J Biol Chem 264 24 1989 14396 14402
11. S. Okret, L. Poellinger, Y. Dong, and J.A. Gustafsson Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone Proc Natl Acad Sci USA 83 16 1986 5899 5903
12. D.J. Waxman, C. Attisano, F.P. Guengerich, and D.P. Lapenson Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme Arch Biochem Biophys 263 2 1988 424 436
13. W.V. Vedeckis, M. Ali, and H.R. Allen Regulation of glucocorticoid receptor protein and mRNA levels Cancer Res 49 8 Suppl. 1989 2295s 2302s
14. W.R. McIntyre, and H.H. Samuels Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form J Biol Chem 260 1 1985 418 427
15. L. Sheflin, B. Keegan, W. Zhang, and S.W. Spaulding Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels Biochem Biophys Res Commun 276 1 2000 144 150
16. E.T. Alarid, N. Bakopoulos, and N. Solodin Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation Mol Endocrinol 13 9 1999 1522 1534
17. D.M. Lonard, Z. Nawaz, C.L. Smith, and B.W. O'Malley The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation Mol Cell 5 6 2000 939 948
18. C.A. Lange, T. Shen, and K.B. Horwitz Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome Proc Natl Acad Sci USA 97 3 2000 1032 1037
19. G. Reid, M.R. Hubner, R. Metivier, H. Brand, S. Denger, and D. Manu Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling Mol Cell 11 3 2003 695 707
20. H.K. Kinyamu, J. Chen, and T.K. Archer Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors J Mol Endocrinol 34 2 2005 281 297
21. B.J. Deroo, C. Rentsch, S. Sampath, J. Young, D.B. DeFranco, and T.K. Archer Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking Mol Cell Biol 22 12 2002 4113 4123
22. A.D. Wallace, and J.A. Cidlowski Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids J Biol Chem 276 46 2001 42714 42721
23. V.E. Allgood, F.E. Powell-Oliver, and J.A. Cidlowski Vitamin B6 influences glucocorticoid receptor-dependent gene expression J Biol Chem 265 21 1990 12424 12433
24. V.E. Allgood, R.H. Oakley, and J.A. Cidlowski Modulation by vitamin B6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor J Biol Chem 268 28 1993 20870 20876
25. P.P. Scheible, T.M. DeLorenzo, and J.A. Cidlowski Analysis of the glucocorticoid antagonist action of dexamethasone 21-mesylate in HeLa S3 cells J Steroid Biochem 26 2 1987 181 187
26. K.L. Burnstein, D.L. Bellingham, C.M. Jewell, F.E. Powell-Oliver, and J.A. Cidlowski Autoregulation of glucocorticoid receptor gene expression Steroids 56 2 1991 52 58
27. S. Sengupta, and B. Wasylyk Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2 Genes Dev 15 18 2001 2367 2380
28. Z. Dvorak, M. Modriansky, J. Ulrichova, P. Maurel, M.J. Vilarem, and J.M. Pascussi Disruption of microtubules leads to glucocorticoid receptor degradation in HeLa cell line Cell Signal 17 2 2005 187 196
29. J.C. Webster, C.M. Jewell, J.E. Bodwell, A. Munck, M. Sar, and J.A. Cidlowski Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein J Biol Chem 272 14 1997 9287 9293
30. L. Whitesell, and P. Cook Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells Mol Endocrinol 10 6 1996 705 712
31. B. Segnitz, and U. Gehring The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin J Biol Chem 272 30 1997 18694 18701
32. P. Connell, C.A. Ballinger, J. Jiang, Y. Wu, L.J. Thompson, and J. Hohfeld The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins Nat Cell Biol 3 1 2001 93 96
33. J. Demand, S. Alberti, C. Patterson, and J. Hohfeld Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling Curr Biol 11 20 2001 1569 1577
34. H.K. Kinyamu, and T.K. Archer Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression Mol Cell Biol 23 16 2003 5867 5881
35. Z. Nawaz, and B.W. O'Malley Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18 3 2004 493 499
36. X. Wang, J.L. Pongrac, and D.B. DeFranco Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity Mol Endocrinol 16 9 2002 1987 1998
37. M.J. Schaaf, and J.A. Cidlowski Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity Mol Cell Biol 23 6 2003 1922 1934
38. M.J. Schaaf, L.J. Lewis-Tuffin, and J.A. Cidlowski Ligand-selective targeting of the glucocorticoid receptor to nuclear subdomains is associated with decreased receptor mobility Mol Endocrinol 19 6 2005 1501 1515
39. J.G. McNally, W.G. Muller, D. Walker, R. Wolford, and G.L. Hager The glucocorticoid receptor: rapid exchange with regulatory sites in living cells Science 287 5456 2000 1262 1265
40. B.C. Freeman, and K.R. Yamamoto Disassembly of transcriptional regulatory complexes by molecular chaperones Science 296 5576 2002 2232 2235
41. D.A. Stavreva, and J.G. McNally Fluorescence recovery after photobleaching (FRAP) methods for visualizing protein dynamics in living mammalian cell nuclei Methods Enzymol 375 2004 443 455
42. D.A. Stavreva, and J.G. McNally Role of H1 phosphorylation in rapid GR exchange and function at the MMTV promoter Histochem Cell Biol 125 1-2 2006 83 89
43. X. Wang, and D.B. DeFranco Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase Mol Endocrinol 19 6 2005 1474 1482
44. C. Li, R.C. Wu, L. Amazit, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley Specific amino acid residues in the basic helix-loop-helix domain of SRC-3 are essential for its nuclear localization and proteasome-dependent turnover Mol Cell Biol 27 4 2007 1296 1308
45. D. Chauhan, T. Hideshima, and K.C. Anderson Proteasome inhibition in multiple myeloma: therapeutic implication Annu Rev Pharmacol Toxicol 45 2005 465 476
46. A. Mani, and E.P. Gelmann The ubiquitin-proteasome pathway and its role in cancer J Clin Oncol 23 21 2005 4776 4789
47. S. Jagannath, B.G. Durie, J. Wolf, E. Camacho, D. Irwin, and J. Lutzky Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma Br J Haematol 129 6 2005 776 783
48. J. Schmielau, C. Teschendorf, M. Konig, W. Schmiegel, and U. Graeven Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma Leuk Lymphoma 46 4 2005 567 569